Seasonal influenza outbreaks kill between 300,000 and 500,000 people every year and cost hundreds of billions of dollars in healthcare and days off work.
Vaccination programmes have reduced the intensity of the impact but - given the interdependent risk of infectious disease transmission - the potential of misaligned incentives in the influenza vaccines’ supply chain may result in less than ideal coverage from a global health viewpoint.